Concomitant highly active antiretroviral therapy leads to smaller decline and faster recovery of CD4+ cell counts during and after pegylated interferon plus ribavirin therapy in HIV-hepatitis C virus coinfected patients. [electronic resource]
Producer: 20110728Description: 1802-6 p. digitalISSN:- 1537-6613
- Adult
- Antiretroviral Therapy, Highly Active -- methods
- Antiviral Agents -- therapeutic use
- CD4 Lymphocyte Count
- CD4-Positive T-Lymphocytes -- drug effects
- Drug Therapy, Combination
- Female
- HIV Infections -- complications
- Hepatitis C -- complications
- Humans
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Male
- Middle Aged
- Polyethylene Glycols -- therapeutic use
- Recombinant Proteins
- Ribavirin -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.